Mitigating permeability-mediated risks in drug discovery

Bibliography

• Wang J. Comprehensive assessment of ADMET risks in drug discovery. Curr Pharm Des 2009;15:2195-219
   PubMed Web of Science ®Google Scholar
• Carlson TJ, Fisher MB. Recent advances in high throughput screening for ADME properties. Comb Chem High Throughput Screen 2008;11:258-64
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
   PubMed Web of Science ®Google Scholar
• Wohnsland F, Faller B. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J Med Chem 2001;44:923-30
   PubMed Web of Science ®Google Scholar
• Irvine JD, Takahashi L, Lockhart K, MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci 1999;88:28-33
   PubMed Web of Science ®Google Scholar
• Sugano K, Takata N, Machida M, Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model. Int J Pharm 2002;241:241-51
   PubMed Web of Science ®Google Scholar
• Avdeef A, Strafford M, Block E, Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst. Eur J Pharm Sci 2001;14:271-80
   PubMed Web of Science ®Google Scholar
• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007-10
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26
   PubMed Web of Science ®Google Scholar
• Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867-77
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Zhang W, Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem 2006;13:2653-67
   PubMed Web of Science ®Google Scholar
• Huque FT, Box K, Platts JA, Comer J. Permeability through DOPC/dodecane membranes: measurement and LFER modelling. Eur J Pharm Sci 2004;23:223-32
   PubMed Web of Science ®Google Scholar
• Fujikawa M, Ano R, Nakao K, Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorg Med Chem 2005;13:4721-32
   PubMed Web of Science ®Google Scholar
• Nakao K, Fujikawa M, Shimizu R, Akamatsu M. QSAR application for the prediction of compound permeability with in silico descriptors in practical use. J Comput Aided Mol Des 2009;23:309-19
   PubMed Web of Science ®Google Scholar
• Winiwarter S, Hilgendorf C. Modeling of drug-transporter interactions using structural information. Curr Opin Drug Discov Devel 2008;11:95-103
   PubMed Web of Science ®Google Scholar
• Wang J, Faller B. Progress in bioanalytics and automation robotics for ADME screening. In: Testa B, van de Waterbeemd H, editors, Comprehensive medicinal chemistry. 2nd edition. Oxford: Elsevier Ltd.; 2007. p. 341-56
   Google Scholar
• Mensch J, Noppe M, Adriaensen J, Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early drug discovery. J Chromatogr B Analyt Technol Biomed Life Sci 2007;847:182-7
   PubMed Web of Science ®Google Scholar
• Balimane PV, Pace E, Chong S, A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis. J Pharm Biomed Anal 2005;39:8-16
   PubMed Web of Science ®Google Scholar
• Avdeef A, Bendels S, Di L, PAMPA–critical factors for better predictions of absorption. J Pharm Sci 2007;96:2893-909
   PubMed Web of Science ®Google Scholar
• Faller B. Artificial membrane assays to assess permeability. Curr Drug Metab 2008;9:886-92
   PubMed Web of Science ®Google Scholar
• Avdeef A. The rise of PAMPA. Expert Opin Drug Metab Toxicol 2005;1:325-42
   PubMedGoogle Scholar
• Sugano K, Hamada H, Machida M, Optimized conditions of bio-mimetic artificial membrane permeation assay. Int J Pharm 2001;228:181-8
   PubMed Web of Science ®Google Scholar
• Zhu C, Jiang L, Chen TM, Hwang KK. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem 2002;37:399-407
   PubMed Web of Science ®Google Scholar
• Avdeef A, Nielsen PE, Tsinman O. PAMPA–a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Eur J Pharm Sci 2004;22:365-74
   PubMed Web of Science ®Google Scholar
• Ruell JA, Tsinman KL, Avdeef A. PAMPA–a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)–optimized design (pOD-PAMPA). Eur J Pharm Sci 2003;20:393-402
   PubMed Web of Science ®Google Scholar
• Cecchelli R, Berezowski V, Lundquist S, Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 2007;6:650-61
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223-32
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Bezar IF, Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci 2009;98:1980-91
   PubMed Web of Science ®Google Scholar
• Yoon CH, Kim SJ, Shin BS, Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography. J Biomol Screen 2006;11:13-20
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Carter GT. Strategies to assess blood-brain barrier penetration. Expert Opin Drug Discov 2008;3:677-87
   PubMed Web of Science ®Google Scholar
• Artursson P, Tavelin S. Caco-2 and emerging alternatives for prediction of intestinal drug transport: a general overview. In: van de Waterbeemd H, Lennernaes H, Artursson P, editors, Drug bioavailability. 18 edition. Weinheim: Wiley-VCH; 2003. p. 72-89
   Google Scholar
• Lennernas H. Intestinal drug absorption and bioavailability: beyond involvement of single transport function. J Pharm Pharmacol 2003;55:429-33
   PubMed Web of Science ®Google Scholar
• Englund G, Rorsman F, Ronnblom A, Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 2006;29:269-77
   PubMed Web of Science ®Google Scholar
• Hilgendorf C, Ahlin G, Seithel A, Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 2007;35:1333-40
   PubMed Web of Science ®Google Scholar
• Ungell AL. Caco-2 replace or refine? Drug Discov Today Technol 2004;1:423-30
   PubMedGoogle Scholar
• Steffansen B, Nielsen CU, Brodin B, Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption. Eur J Pharm Sci 2004;21:3-16
   PubMed Web of Science ®Google Scholar
• Liang E, Chessic K, Yazdanian M. Evaluation of an accelerated Caco-2 cell permeability model. J Pharm Sci 2000;89:336-45
   PubMed Web of Science ®Google Scholar
• Lakeram M, Lockley DJ, Sanders DJ, Paraben transport and metabolism in the biomimetic artificial membrane permeability assay (BAMPA) and 3-day and 21-day Caco-2 cell systems. J Biomol Screen 2007;12:84-91
   PubMed Web of Science ®Google Scholar
• Uchida M, Fukazawa T, Yamazaki Y, A modified fast (4 day) 96-well plate Caco-2 permeability assay. J Pharmacol Toxicol Methods 2009;59:39-43
   PubMedGoogle Scholar
• Alsenz J, Haenel E. Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis. Pharm Res 2003;20:1961-9
   PubMed Web of Science ®Google Scholar
• Press B, Di GD. Permeability for intestinal absorption: Caco-2 assay and related issues. Curr Drug Metab 2008;9:893-900
   PubMed Web of Science ®Google Scholar
• Balimane PV, Han YH, Chong S. Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J 2006;8:E1-13
   PubMed Web of Science ®Google Scholar
• Volpe DA. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J Pharm Sci 2008;97:712-25
   PubMed Web of Science ®Google Scholar
• Lakeram M, Lockley DJ, Pendlington R, Forbes B. Optimisation of the Caco-2 permeability assay using experimental design methodology. Pharm Res 2008;25:1544-51
   PubMed Web of Science ®Google Scholar
• Fossati L, Dechaume R, Hardillier E, Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs. Int J Pharm 2008;360:148-55
   PubMedGoogle Scholar
• Hochman JH, Yamazaki M, Ohe T, Lin JH. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein. Curr Drug Metab 2002;3:257-73
   PubMed Web of Science ®Google Scholar
• Varma MV, Perumal OP, Panchagnula R. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol 2006;10:367-73
   PubMed Web of Science ®Google Scholar
• Troutman MD, Thakker DR. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm Res 2003;20:1200-9
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharmacol Toxicol Methods 2000;44:301-12
   PubMed Web of Science ®Google Scholar
• Bohets H, Annaert P, Mannens G, Strategies for absorption screening in drug discovery and development. Curr Top Med Chem 2001;1:367-83
   PubMedGoogle Scholar
• Thiel-Demby VE, Humphreys JE, St John Williams LA, Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. Mol Pharm 2009;6:11-8
   PubMed Web of Science ®Google Scholar
• Matsson P, Bergstrom CA, Nagahara N, Exploring the role of different drug transport routes in permeability screening. J Med Chem 2005;48:604-13
   PubMed Web of Science ®Google Scholar
• Wang Q, Rager JD, Weinstein K, Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. Int J Pharm 2005;288:349-59
   PubMed Web of Science ®Google Scholar
• Faassen F, Vogel G, Spanings H, Vromans H. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm 2003;263:113-22
   PubMed Web of Science ®Google Scholar
• Garberg P, Ball M, Borg N, In vitro models for the blood-brain barrier. Toxicol In Vitro 2005;19:299-334
   PubMed Web of Science ®Google Scholar
• Lundquist S, Renftel M. The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry–background and current status in the drug discovery process. Vascul Pharmacol 2002;38:355-64
   PubMed Web of Science ®Google Scholar
• Terasaki T, Ohtsuki S, Hori S, New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov Today 2003;8:944-54
   PubMed Web of Science ®Google Scholar
• Hansen DK, Scott DO, Otis KW, Lunte SM. Comparison of in vitro BBMEC permeability and in vivo CNS uptake by microdialysis sampling. J Pharm Biomed Anal 2002;27:945-58
   PubMed Web of Science ®Google Scholar
• Lundquist S, Renftel M, Brillault J, Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res 2002;19:976-81
   PubMed Web of Science ®Google Scholar
• Weksler BB, Subileau EA, Perriere N, Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19:1872-4
   PubMed Web of Science ®Google Scholar
• Reichel A, Begley DJ, Abbott NJ. An overview of in vitro techniques for blood-brain barrier studies. Methods Mol Med 2003;89:307-24
   PubMedGoogle Scholar
• Nicolazzo JA, Charman SA, Charman WN. Methods to assess drug permeability across the blood-brain barrier. J Pharm Pharmacol 2006;58:281-93
   PubMed Web of Science ®Google Scholar
• Lennernas H, Ahrenstedt O, Hallgren R, Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res 1992;9:1243-51
   PubMed Web of Science ®Google Scholar
• Lennernas H. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. Curr Drug Metab 2007;8:645-57
   PubMed Web of Science ®Google Scholar
• Knutson T, Fridblom P, Ahlstrom H, Increased understanding of intestinal drug permeability determined by the LOC-I-GUT approach using multislice computed tomography. Mol Pharm 2009;6:2-10
   PubMed Web of Science ®Google Scholar
• Lennernas H, Lee ID, Fagerholm U, Amidon GL. A residence-time distribution analysis of the hydrodynamics within the intestine in man during a regional single-pass perfusion with Loc-I-Gut: in-vivo permeability estimation. J Pharm Pharmacol 1997;49:682-6
   PubMed Web of Science ®Google Scholar
• Sasongko L, Link JM, Muzi M, Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography. Clin Pharmacol Ther 2005;77:503-14
   PubMed Web of Science ®Google Scholar
• Yasui-Furukori N, Uno T, Sugawara K, Tateishi T. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Clin Pharmacol Ther 2005;77:17-23
   PubMed Web of Science ®Google Scholar
• Lennernas H. Animal data: the contributions of the using chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev 2007;59:1103-20
   PubMed Web of Science ®Google Scholar
• Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 1996;13:1336-42
   PubMed Web of Science ®Google Scholar
• Cao X, Gibbs ST, Fang L, Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 2006;23:1675-86
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharm Sci 2007;10:368-79
   PubMed Web of Science ®Google Scholar
• Chiou WL, Barve A. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 1998;15:1792-5
   PubMed Web of Science ®Google Scholar
• Chiou WL, Ma C, Chung SM, Similarity in the linear and non-linear oral absorption of drugs between human and rat. Int J Clin Pharmacol Ther 2000;38:532-9
   PubMed Web of Science ®Google Scholar
• Dahan A, Amidon GL. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Mol Pharm 2009;6:19-28
   PubMed Web of Science ®Google Scholar
• Ueda S, Yamaoka K, Nakagawa T. Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference. J Pharm Pharmacol 1999;51:585-9
   PubMed Web of Science ®Google Scholar
• Hoffman DJ, Seifert T, Borre A, Nellans HN. Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling. Pharm Res 1995;12:889-94
   PubMed Web of Science ®Google Scholar
• Yuasa H, Matsuda K, Watanabe J. Influence of anesthetic regimens on intestinal absorption in rats. Pharm Res 1993;10:884-8
   PubMed Web of Science ®Google Scholar
• Griffin B, O'driscoll C. Models of the small intestine. In: Ehrhardt C, Kim K, editors, Drug absorption studies: in situ, in vitro, and in silico models. New York: Springer; 2008. p. 34-76
   Google Scholar
• Fujieda Y, Yamaoka K, Ito T, Nakagawa T. Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference. Pharm Res 1996;13:1201-4
   PubMed Web of Science ®Google Scholar
• Lindahl A, Sjoberg A, Bredberg U, Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2. Mol Pharm 2004;1:347-56
   PubMed Web of Science ®Google Scholar
• Nejdfors P, Ekelund M, Jeppsson B, Westrom BR. Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: species- and region-related differences. Scand J Gastroenterol 2000;35:501-7
   PubMed Web of Science ®Google Scholar
• Bajka BH, Gillespie CM, Steeb CB, Applicability of the using chamber technique to permeability determinations in functionally distinct regions of the gastrointestinal tract in the rat. Scand J Gastroenterol 2003;38:732-41
   PubMed Web of Science ®Google Scholar
• Johnson BM, Charman WN, Porter CJ. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. Drug Metab Dispos 2003;31:1151-60
   PubMed Web of Science ®Google Scholar
• Deferme S, Annaert P, Augustijns P. In vitro screening models to assess intestinal drug absorption and metabolism. In: Ehrhardt C, Kim K, editors. Drug absorption studies: in situ, in vitro, and in silico models. New York: Springer; 2008. p. 182-215
   Google Scholar
• Smith QR. A review of blood-brain barrier transport techniques. Methods Mol Med 2003;89:193-208
   PubMedGoogle Scholar
• Pardridge WM. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv Drug Deliv Rev 1995;15:5-36
   PubMed Web of Science ®Google Scholar
• Bonate PL. Animal models for studying transport across the blood-brain barrier. J Neurosci Methods 1995;56:1-15
   PubMed Web of Science ®Google Scholar
• Wang J, Urban L, Bojanic D. Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opin Drug Metab Toxicol 2007;3:641-65
   PubMed Web of Science ®Google Scholar
• Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 2007;6:881-90
   PubMed Web of Science ®Google Scholar
• Bender A, Scheiber J, Glick M, Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. ChemMedChem 2007;2:861-73
   PubMed Web of Science ®Google Scholar
• Kerns EH, Di L, Petusky S, Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J Pharm Sci 2004;93:1440-53
   PubMed Web of Science ®Google Scholar
• Stoner C, Troutman MD, Gao H, Moving in silico screening into practice: a minimalist approach to guide permeability screening. Lett Drug Des Discov 2006;3:575-81
   Web of Science ®Google Scholar
• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-49
   PubMed Web of Science ®Google Scholar
• Curatolo W. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. 1 edition. 1998. p. 387-93
   Google Scholar
• Lennernas H, Abrahamsson B. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J Pharm Pharmacol 2005;57:273-85
   PubMed Web of Science ®Google Scholar
• Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22:11-23
   PubMed Web of Science ®Google Scholar
• Gleeson MP. Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 2008;51:817-34
   PubMed Web of Science ®Google Scholar
• Li C, Liu T, Broske L, Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans. Biochem Pharmacol 2008;76:1757-64
   PubMed Web of Science ®Google Scholar
• Dreassi E, Zizzari AT, Falchi F, Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data. Eur J Med Chem 2009;44:3712-7
   PubMed Web of Science ®Google Scholar
• Fagerholm U. The role of permeability in drug ADME/PK, interactions and toxicity–presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans. Pharm Res 2008;25:625-38
   PubMed Web of Science ®Google Scholar
• Wang J, Skolnik S. Recent advances in physicochemical and ADMET profiling in drug discovery. Chem Biodivers 2009; in press
   Google Scholar
• Migliavacca E. Applied introduction to multivariate methods used in drug discovery. Mini Rev Med Chem 2003;3:831-48
   PubMedGoogle Scholar
• Zhou L, Yang L, Tilton S, Wang J. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery. J Pharm Sci 2007;96:3052-71
   PubMed Web of Science ®Google Scholar